RecruitingNot Applicable

Effect of Onion Extract Nanoparticle Gel Phonophoresis on Postsurgical Scar of Cesarean Section.

Egypt40 participantsStarted 2024-09-12

Plain-language summary

Cesarean section is one of the most common abdominal operations performed on women. The cesarean section rate is rising rapidly and continuously in many parts of the world. The cesarean-section surgery leaves a scar that requires special care. A horizontal skin incision approximately 10-15 cm long is usually performed during the procedure. Apart from the skin, the following: subcutaneous tissue, fascia, peritoneum, and uterine muscle are cut leaving traces in the form of scars and accompanying ailments, on the one hand, such as pain, tenderness, and hypersensitivity to stimuli, and on the other, limitations, such as contractures or impairment of tissue mobility

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Their ages will be ≥18 years old. All women had given birth via elective abdominal transversal C-section for the first time. All women suffering from Postsurgical Scar Of Cesarean-Section about 2-3 months post-surgery. All women will provide an informed consent form agreeing to participate and publication of the study results Exclusion Criteria: Any pathological conditions or associated injuries affect the result of the study. Skin disease. Cognitive and psychological impairment. Patients have implanted electronic devices, such as cardiac pacemakers, to prevent ultrasound interference. Women with diabetes, cardiovascular problems, or a previous history of any disorder may alter sensation and delay the healing process which counteracts the study's goal.

What they're measuring

Modified Vancouver scar scale

Timeframe: 12 weeks

Tonometer

Timeframe: 12 weeks

Trial details

NCT IDNCT06658444

SponsorOctober 6 University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

Contact for this trial

Heba Haridy, doctoral

01117671712 Heba.Ahmed.PT@o6u.edu.eg